Abstract |
Photodynamic therapy ( PDT) has been developed as a promising treatment modality for laryngeal cancer. 9-Hydroxypheophorbide α (9-HPbD), a novel chlorophyll-derived photosensitizer, has a longer absorption wavelength, which increases the penetration of light to malignant tissues. Carboplatin ( CBDCA), a second-generation platinum derivative, also has gained more popularity for the treatment of laryngeal cancer. Our previous studies have elucidated that 9-HPbD-PDT could inhibit the migration and invasion of HEp-2 cells. The objective of this study is to investigate the change of migration and invasion of HEp-2 cells induced by a combined modality of CBDCA and 9-HPbD-PDT in vitro. A wound healing assay, cell migration assay and Matrigel invasion assay were used to evaluate the cellular migration and invasion. Reactive oxygen species (ROS) and Western blots for epithelial-mesenchymal transition (EMT) markers ( E-cadherin, N-cadherin and vimentin), MMPs (MMP-2 and MMP-9) and MEK/ERK signalling pathway were performed to investigate the possible mechanisms that may be involved. We observed that CBDCA and 9-HPbD-PDT administration synergistically inhibited the migration and invasion of HEp-2 cells. Moreover, the combined modality cooperatively repressed the EMT process and down-regulated expressions of MMP-2 and MMP-9 via ROS-mediated inhibition of phosphorylation in the MEK/ERK signalling pathway. Our results suggested that the combination of CBDCA and 9-HPbD-PDT might be a promising therapeutic strategy for laryngeal cancer metastasis.
|
Authors | Wenjing Mao, Yan Sun, Huankang Zhang, Luhong Cao, Jiajia Wang, Peijie He |
Journal | Lasers in medical science
(Lasers Med Sci)
Vol. 31
Issue 8
Pg. 1697-1705
(Nov 2016)
ISSN: 1435-604X [Electronic] England |
PMID | 27481258
(Publication Type: Journal Article)
|
Chemical References |
- 9-hydroxypheophorbide alpha
- Photosensitizing Agents
- Reactive Oxygen Species
- Chlorophyll
- Carboplatin
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 9
|
Topics |
- Carboplatin
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Chlorophyll
(analogs & derivatives, pharmacology, therapeutic use)
- Combined Modality Therapy
- Epithelial-Mesenchymal Transition
(drug effects)
- Humans
- Laryngeal Neoplasms
(drug therapy, enzymology, pathology)
- MAP Kinase Signaling System
(drug effects)
- Matrix Metalloproteinase 2
(metabolism)
- Matrix Metalloproteinase 9
(metabolism)
- Neoplasm Invasiveness
- Phosphorylation
(drug effects)
- Photochemotherapy
- Photosensitizing Agents
(pharmacology, therapeutic use)
- Reactive Oxygen Species
(metabolism)
|